Cargando…

Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes

AIM: To identify risk factors predictive of or associated with gastrointestinal side effects (GISE) of liraglutide in patients with type 2 diabetes (T2DM). METHODS: T2DM patients treated with liraglutide for the first time were obtained and grouped into patients without GSEA and patients with GSEA....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Hao, Lu, Zongshi, Chen, Runyao, Cai, Quanfang, Wang, Miaomiao, Zhang, Liting, Zhu, Zhiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922750/ https://www.ncbi.nlm.nih.gov/pubmed/36793278 http://dx.doi.org/10.3389/fendo.2023.1098032

Ejemplares similares

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes
por: Su, Yu, et al.
Publicado: (2023)

Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes
por: Tan, Yijiong, et al.
Publicado: (2022)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Hansen, Christian Stevns, et al.
Publicado: (2019)

A Diabetic Patient Complicated With Pancreatic Cancer After Using Liraglutide: A Case Report
por: Wu, Shengjie, et al.
Publicado: (2021)

The Discovery and Development of Liraglutide and Semaglutide
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2019)

Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus
por: Du, Juan, et al.
Publicado: (2023)

Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients
por: Zameer, Rafia, et al.
Publicado: (2020)

The effects of prebiotics on gastrointestinal side effects of metformin in youth: A pilot randomized control trial in youth-onset type 2 diabetes
por: Dixon, Sydney A., et al.
Publicado: (2023)

Liraglutide Inhibits Osteoclastogenesis and Improves Bone Loss by Downregulating Trem2 in Female Type 1 Diabetic Mice: Findings From Transcriptomics
por: Yu, Jie, et al.
Publicado: (2021)

Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
por: El-Shafey, Mohamed, et al.
Publicado: (2022)

Exploring Cardio-Metabolic Effects of Liraglutide in Patients With Type 2 Diabetes Through a Proteomic Approach
por: Ekhzaimy, Aishah Ali, et al.
Publicado: (2021)

Liraglutide Activates Type 2 Deiodinase and Enhances β3-Adrenergic-Induced Thermogenesis in Mouse Adipose Tissue
por: Oliveira, Fernanda C. B., et al.
Publicado: (2022)

Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes
por: Seo, Young-Gyun
Publicado: (2021)

Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
por: Nyström, Thomas, et al.
Publicado: (2017)

Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity
por: Caputo, Marina, et al.
Publicado: (2021)

Tandem mass tag-based proteomic profiling revealed potential therapeutic targets and mechanisms of liraglutide for the treatment of impaired glucose tolerance
por: Guo, Qiuyue, et al.
Publicado: (2022)

Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
por: Nyström, Thomas, et al.
Publicado: (2018)

Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [(64)Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial
por: Jensen, Jacob K., et al.
Publicado: (2021)

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014)

Circulating Fibroblast Growth Factor 21 and Total Testosterone in Type 2 Diabetes Mellitus Men With Coronary Heart Disease
por: Mei, Yufeng, et al.
Publicado: (2022)

Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
por: Huang, Yuxin, et al.
Publicado: (2022)

Liraglutide in the management of type 2 diabetes
por: Wajcberg, Estela, et al.
Publicado: (2010)

Effects of liraglutide or lifestyle interventions combined with other antidiabetic drugs on abdominal fat distribution in people with obesity and type 2 diabetes mellitus evaluated by the energy spectrum ct: A prospective randomized controlled study
por: Yu, Dongni, et al.
Publicado: (2022)

The risk factors of type 2 diabetes in hypertensive subjects
por: Chen, Yingqun, et al.
Publicado: (2022)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials
por: Dömötör, Zsuzsa Réka, et al.
Publicado: (2020)

Incidence and Risk Factors of Hypogonadism in Male Patients With Latent Autoimmune Diabetes and Classic Type 2 Diabetes
por: Cai, Meili, et al.
Publicado: (2021)

Degree of obesity and gastrointestinal adverse reactions influence the weight loss effect of liraglutide in overweight or obese patients with type 2 diabetes
por: Zhou, Fang, et al.
Publicado: (2023)

Environmental Factors Associated With Type 1 Diabetes
por: Esposito, Susanna, et al.
Publicado: (2019)

Potential of liraglutide in the treatment of patients with type 2 diabetes
por: Deacon, Carolyn F
Publicado: (2009)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
por: Rigato, Mauro, et al.
Publicado: (2014)

Liraglutide-Induced Pancreatitis: A Case Report and Literature Review
por: Javed, Hamna, et al.
Publicado: (2023)

Safety and Efficacy of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
por: Vemulapalli, Hema Srikanth, et al.
Publicado: (2023)

Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY(3-36) Combination Therapy in Diet-Induced Obese Rats
por: Dischinger, Ulrich, et al.
Publicado: (2021)

The melatonin receptor 1B gene links circadian rhythms and type 2 diabetes mellitus: an evolutionary story
por: Zhu, Hui, et al.
Publicado: (2023)

Editorial: Chronology of gastrointestinal cancers and gastrointestinal microbiota
por: Mi, Yang, et al.
Publicado: (2023)

The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy
por: Yuan, Bo, et al.
Publicado: (2022)

Elderly rats fed with a high-fat high-sucrose diet developed sex-dependent metabolic syndrome regardless of long-term metformin and liraglutide treatment
por: Ivić, Vedrana, et al.
Publicado: (2023)

Gastrointestinal Helminth Infection Improves Insulin Sensitivity, Decreases Systemic Inflammation, and Alters the Composition of Gut Microbiota in Distinct Mouse Models of Type 2 Diabetes
por: Khudhair, Zainab, et al.
Publicado: (2021)

Liraglutide and DPP-4 inhibitors – side effects comparative clinical study
por: TIMOFTE, LUMINIŢA, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0168m0lvlkki3iovpdc37j36q0